Forest Laboratories | Pharma Commons 2012-07-10 07:00:00

Activist investor Carl Icahn said he had initially tried to avoid a proxy fight against Forest Laboratories Inc and had offered to take at least two seats on the U.S. drugmaker's board, but he was reb…